Bouygues has been picked to build a health facility in west London to speed up the diagnosis of cancer and other illnesses.
The UK arm of the French firm was named as lead contractor for the design and build of the Ambulatory Diagnostic Centre at West Middlesex University Hospital.
Chelsea and Westminster Hospital NHS Foundation Trust made the appointment following a competitive process. The demolition of an existing MRI building on the site has begun.
The replacement five-storey facility was approved by councillors in early 2023, when the entire scheme was expected to cost £73m. The NHS trust has since said the project will cost around £80m.
The hospital building will provide diagnostic and treatment services for cancer, renal and imaging to residents in the boroughs of Hounslow, Richmond and Ealing.
The hub is designed to reduce health inequalities, improve patient outcomes and provide care closer to home, freeing up space in the main hospital for in-patient care.
A ground-floor corridor will link the new hub to the existing hospital building, while the rooftop will feature plant and a terrace.
Bouygues said it would support the local community through apprenticeships and work experience placements, as well as working with educational institutions in the area and taking part in charity initiatives.
The contractor is currently working in partnership with training provider MITSkills, the London Borough of Hounslow and JobCentre Plus Hounslow on a skills development programme and sustainable long-term employment opportunities for local people.
Bouygues chief executive Fabienne Viala said the firm was “thrilled” to be working with Chelsea and Westminster Hospital NHS Foundation Trust.
“This project underscores our commitment to delivering sustainable, state-of-the-art facilities that will significantly benefit the local community,” she added.
Chelsea and Westminster Hospital NHS Foundation Trust chief executive Lesley Watts said the new centre would provide a “vital service” for local residents.
“Most importantly it will improve early diagnosis and health outcomes for patients in our community for years to come,” she added.
Bouygues UK completed University College London Hospital’s Grafton Way cancer and surgery centre in 2022, and is working on the £300m Oriel integrated eye care, research and education facility in Camden.
